SecBot SecBot
SECBOTREPLAY Home › Report › NVO

NVO · CSO sells 12,000 shares

NOVO NORDISK A S · 6-K filed Nov 5, 2026 at 13:06 ET

At the news

NEUTRALIMPACT 2/10

6-K filed Nov 5, 2026 at 13:06 ET

Novo Nordisk filed a Form 6-K disclosing a share sale by Executive Vice President and CSO Martin Holst Lange. He sold 12,000 B shares at DKK 285.00 per share, for a total of DKK 3,420,000. This is a routine insider sale disclosure with no material financial impact.

  • Martin Holst Lange (EVP, R&D and CSO) sold 12,000 Novo Nordisk B shares
  • Sale price: DKK 285.00 per share
  • Total proceeds: DKK 3,420,000
  • Transaction date: November 4, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access